51黑料吃瓜在线观看,51黑料官网|51黑料捷克街头搭讪_51黑料入口最新视频

設(shè)為首頁(yè) |  加入收藏
首頁(yè)首頁(yè) 期刊簡(jiǎn)介 消息通知 編委會(huì) 電子期刊 投稿須知 廣告合作 聯(lián)系我們
狹窄幾何參數(shù)評(píng)估穩(wěn)定型冠心病心肌灌注效能的指導(dǎo)價(jià)值

Guiding value of stenosis geometrical parameters in evaluating myocardial perfusion efficacy in stable coronary heart disease

作者: 白蘭  李娜  馮懿俐  席曉璐  孫昊  許可  喬愛(ài)科  楊海勝  劉健  劉有軍  
單位:北京工業(yè)大學(xué)環(huán)境與生命學(xué)部生命科學(xué)與化學(xué)學(xué)院(北京100124) <p>,北京大學(xué)人民醫(yī)院(北京100044)</p> <p>通信作者:劉有軍。E-mail: [email protected]</p> <p>&nbsp;</p>
關(guān)鍵詞: 冠狀動(dòng)脈狹窄;病變累及長(zhǎng)度;病變嚴(yán)重程度;心肌灌注;效能評(píng)估  
分類號(hào):R318.04
出版年·卷·期(頁(yè)碼):2021·40·4(360-366)
摘要:

目的 探討?yīng)M窄病變嚴(yán)重程度和病變累及長(zhǎng)度等狹窄形態(tài)特征對(duì)穩(wěn)定型冠心病心肌灌注效能的評(píng)估價(jià)值,提出一項(xiàng)定性定量描述冠心病局域心肌灌注效能的預(yù)測(cè)指標(biāo)。方法 將54例穩(wěn)定型冠心病患者納入統(tǒng)計(jì)研究,對(duì)其行冠狀動(dòng)脈造影及FFR檢查測(cè)量,對(duì)反映心肌灌注效能的狹窄病變嚴(yán)重程度和病變累及長(zhǎng)度等狹窄形態(tài)幾何參數(shù)進(jìn)行量化分析,包括α值(反映病變嚴(yán)重程度,α=D min/D normal),β值(反映病變累及長(zhǎng)度),α×β值(反映局部心肌血流供需關(guān)系)。結(jié)果 納入分析的54組病變數(shù)據(jù)中,未發(fā)生心肌灌注不良者(FFR ≥0.8)43例,心肌灌注不良者(FFR <0.8)11例,心肌灌注不良組α值,β值與未發(fā)生心肌灌注不良組間無(wú)顯著相關(guān)性(P >0.05),但心肌灌注不良組的α×β明顯大于未發(fā)生心肌灌注不良組(P <0.05)。ROC曲線分析顯示,通過(guò)α×β值評(píng)估病變對(duì)于心肌灌注影響的曲線下面積為0.783 (95% CI:0.603~0.964),敏感度為63.6%,特異度為93.0%,陽(yáng)性預(yù)測(cè)值為70.0%,陰性預(yù)測(cè)值為90.9%,評(píng)估準(zhǔn)確度為92.6%。結(jié)論 α×β值較大組別對(duì)應(yīng)的臨床FFR值更小,該項(xiàng)指標(biāo)與心肌灌注效能之間具有較強(qiáng)敏感性,這與臨床現(xiàn)象一致。提示α×β這一指標(biāo)可定性定量描述冠心病心肌灌注效能,為輔助評(píng)價(jià)狹窄支血管是否發(fā)生局域心肌灌注不足提供理論支持。

Objective

Objective To explore the value of the stenosis morphological characteristics. We would propose a predictor to evaluate the efficacy of myocardial perfusion in stable coronary heart disease. The severity of stenosis lesion and the length of lesion involvement are included. It can qualitatively and quantitatively evaluate efficacy of regional myocardial perfusion in coronary heart disease. Methods 54 patients with stable coronary artery disease are included in research. They were measured by coronary angiography and FFR. The stenosis geometrical parameters including α (reflecting lesion severity, α=D min/D normal), β (reflecting lesion involvement length) and α×β (reflecting local supply and demand relationship of myocardial blood flow) were quantitatively analyzed. Results Among the 54 groups, 43 patients with no myocardial ischemia (FFR ≥0.8) and 11 patients with poor myocardial perfusion (FFR <0.8). There was no significant correlation between the FFR ≥0.8 group and FFR <0.8, but the α×β of FFR <0.8 group was significantly higher than that the FFR ≥0.8 group (P <0.05). And the area under the ROC curve for evaluating myocardial perfusion by α×β value was 0.783 (95%CI: 0.603-0.964), the sensitivity, specificity, positive predictive value, negative predictive value and evaluation accuracy were respectively 63.6%, 93.0%, 70.0%, 90.9% and 92.6%. Conclusions Patients with higher α×β value had lower FFR There was a strong sensitivity between this index and myocardial perfusion efficacy. It was consistent with the clinical phenomenon.

The α×β index can qualitatively and quantitatively describe the efficacy of myocardial perfusion in coronary heart disease, it can provide a theoretical support for the auxiliary evaluation whether myocardial insufficiency occurs.

 

參考文獻(xiàn):

[1] 余丹青, 林曙光, 周穎玲,等. 血管內(nèi)超聲對(duì)急性冠狀動(dòng)脈綜合征臨界病變治療決策的影響[J]. 中華心血管病雜志, 2011, 39(2):137-141.

Yu DQ, Lin SG, Zhou YL, et al. Vulnerable plaque burden post pharmacological and interventional treatments in patients with acute coronary syndrome and borderline lesion: intravascular ultrasound follow up results [J].Chinese Journal of Cardiology, 2011, 39(2): 137-141.

[2] Kruk M, Wardziak L, Demkow M, et al. Workstation-based calculation of CTA-based FFR for intermediate stenosis[J]. JACC: Cardiovascular Imaging, 2016, 9(6): 690-699.

[3] Wardziak L, Kruk M, Pleban W, et al. Coronary CTA enhanced with CTA based FFR analysis provides higher diagnostic value than invasive coronary angiography in patients with intermediate coronary stenosis [J]. Journal of Cardiovascular Computed Tomography, 2019, 13(1): 62-67.

[4] Harvey JE, Ellis SG. Intracoronary hemodynamic assessment: coronary flow reserve (CFR) and fractional flow reserve (FFR) [M]// Cardiovascular Hemodynamics.Totowa, NJ: ?Humana Press, 2013: 319-331.

[5] Li Y, Shi ZT, Cai Y, et al. Impact of coronary tortuosity on coronary pressure: numerical simulation study [J]. PloS One, 2012, 7(8): e42558.

[6] Ben-Dor I, Torguson R, Deksissa T, et al. Intravascular ultrasound lumen area parameters for assessment of physiological ischemia by fractional flow reserve in intermediate coronary artery stenosis [J]. Cardiovascular Revascularization Medicine, 2012, 13(3): 177–182.

[7] Jang JS, Song YJ, Jin HY, et al. TCT-347 assessment of intravascular ultrasound-derived minimal lumen area and fractional flow reserve to evaluate functionally significant coronary artery disease: a meta-analysis [J]. Journal of the American College of Cardiology, 2014, 64(11): B101.

[8] Han JK, Koo BK, Park KW, et al. Optimal intravascular ultrasound criteria for defining the functional significance of intermediate coronary stenosis: an international multicenter study [J]. Cardiology, 2014, 127(4): 256-262.

[9] Tonino PA, De Bruyne B, Pijls NH, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention [J]. New England Journal of Medicine, 2009, 360(3): 213–224.

[10] Shibutani H, Fujii K, Matsumura K, et al. Differential influence of lesion length on fractional flow reserve in intermediate coronary lesions between each coronary artery [J]. Catheterization and Cardiovascular Interventions, 2019, 95 (6): E168-E174.

[11] Balta S, Demirkol S, Arslan Z, et al. Impact of lesion length on functional significance in intermediate coronary lesions[J]. Clinical Cardiology, 2013, 36(5): 301.

[12] Brosh D, Higano ST, Lennon RJ, et al. Effect of lesion length on fractional flow reserve in intermediate coronary lesions [J]. American Heart Journal, 2005, 150(2): 338-343.?

[13] López-Palop R, Carrillo P, Cordero A, et al. Effect of lesion length on functional significance of intermediate long coronary lesions [J]. Catheterization and Cardiovascular Interventions, 2012, 81(4): E186-E194.

[14] 池黎彤, 劉挨師. CT-FFR對(duì)冠狀動(dòng)脈狹窄功能評(píng)價(jià)的臨床價(jià)值[J].國(guó)際醫(yī)學(xué)放射學(xué)雜志, 2016,39(3):250-253.

Chi LT, Liu AS. The clinical value of CT-FFR in the evaluation of coronary artery stenosis [J].International Journal of Medical Radiology, 2016, 39(3):250-253.

[15] Chung WY, Choi BJ, Lim SH, et al. Three dimensional quantitative coronary angiography can detect reliably ischemic coronary lesions based on fractional flow reserve [J]. Journal of Korean Medical Science, 2015, 30(6):716-724.

[16] Ko B, Cameron J, Leung M, et al. Combined CT coronary angiography and myocardial perfusion imaging to detect functionally significant coronary stenoses in suspected coronary artery disease—comparison with fractional flow reserve [J]. Heart, Lung and Circulation, 2012, 21(Suppl 1): S191.

[17] Waller AH, Blankstein R, Kwong RY, et al. Myocardial blood flow quantification for evaluation of coronary artery disease by positron emission tomography, cardiac magnetic resonance imaging, and computed tomography [J]. Current Cardiology Reports, 2014, 16(5): 483.

[18] 吳玉塘. 探討壓力導(dǎo)絲測(cè)定心肌血流儲(chǔ)備分?jǐn)?shù)(FFR)在冠心病彌漫性長(zhǎng)病變介入治療中的應(yīng)用[J]. 中國(guó)醫(yī)療器械信息, 2017, 23(24): 127-129.

[19] Sakurai S, Takashima H, Waseda K, et al. Influence of plaque characteristics on fractional flow reserve for coronary lesions with intermediate to obstructive stenosis: insights from integrated-backscatter intravascular?? ultrasound analysis [J]. The International Journal of Cardiovascular Imaging, 2015, 31(7): 1295-1301.

[20] Schlett CL, Ferencik M, Celeng C, et al. How to assess non-calcified plaque in CT angiography: delineation methods affect diagnostic accuracy of low-attenuation plaque by CT for lipid-core plaque in histology [J]. European Heart Journal Cardiovascular Imaging, 2013, 14(11): 1099-1105.

?

服務(wù)與反饋:
文章下載】【加入收藏
提示:您還未登錄,請(qǐng)登錄!點(diǎn)此登錄
 
友情鏈接  
地址:北京安定門外安貞醫(yī)院內(nèi)北京生物醫(yī)學(xué)工程編輯部
電話:010-64456508  傳真:010-64456661
電子郵箱:[email protected]